Research & Development
FDA approves Johnson & Johnson's IMAAVY (nipocalimab-aahu) to treat warm autoimmune haemolytic anaemia
25 August 2026 - Healthcare products company Johnson & Johnson (NYSE:JNJ) announced on Monday that the US Food and Drug Administration (FDA) has approved IMAAVY (nipocalimab-aahu) for the treatmen...
Labcorp to offer FDA-cleared pTau-217 blood test for Alzheimer's assessment
24 August 2026 - US laboratory services company Labcorp Holdings, Inc. (NYSE: LH) announced on Monday that, following US Food and Drug Administration clearance, it will offer the Elecsys pTau-217 test...
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
24 August 2026 - Medical technology company Tempus AI Inc (NASDAQ: TEM) reported on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-ena...
European Commission grants orphan designation for Vanda's imsidolimab
24 August 2026 - US biopharmaceutical company Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), said on Monday it has received European Commission orphan designation for imsidolimab, its investigational mono...
United Therapeutics wins FDA acceptance for ralinepag PAH filing
24 August 2026 - Biotechnology company United Therapeutics Corporation (Nasdaq:UTHR) said on Monday that the US Food and Drug Administration (FDA) has accepted its New Drug Application for ralinepag t...
Acadia wins EU approval for DAYBU as first treatment for Rett syndrome
24 August 2026 - Acadia Pharmaceuticals Inc (Nasdaq:ACAD), a developer of treatments for neurological and rare diseases, announced on Monday that the European Commission has granted marketing authoris...